Zu den Inhalten springen
Marien Hospital Herne
St. Elisabeth Gruppe
HomeHome
Medizinische Klinik I - Allgemeine Innere, Nephrologie, Gastroenterologie, Pneumologie

Studien

Chronische Nierenerkrankungen/ Bluthochdruck

BaxDuo Arctic: A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure

BaxDuo Pacific: A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure (BaxDuo-Pacific)

EASi-KIDNEY:
A Multicenter, International, Randomized, Double-blind, Placebo-controlled Clinical Trial of the Aldosterone Synthase Inhibitor BI 690517 in Combination With Empagliflozin in Patients With Chronic Kidney Disease

Niere

SIRIUS-LN - CVAY36K12301: A randomized, double-blind, parallel group, placebo-controlled, multicenter phase 3 trial to evaluate the efficacy, safety and tolerability of ianalumab on top of standard-of-care therapy in participants with active lupus nephritis (SIRIUS-LN)

Versorgungsprojekt

eliPfad: Personalisierter, interdisziplinärer Patientenpfad zur sektorenübergreifenden Versorgung multimorbider Patientinnen und Patienten

Ansprechpartner

Klinikdirektor
Prof. Dr. med. Timm H. Westhoff

Katja Fritz

Katja Fritz
Gesamtleitung Studienzentrum
Fon: 0 23 23 - 499 - 6290
E-Mail: studienkoordination@
elisabethgruppe.de

© Marien Hospital Herne | Impressum | . Datenschutz | . Datenschutz­einstellungen anpassen.